Report Summary:
The report titled "Induced Pluripotent Stem Cells (iPSCs) Market" offers a primary overview of the Induced Pluripotent Stem Cells (iPSCs) industry covering different product definitions, classifications, and participants in the industry chain structure. The quantitative and qualitative analysis is provided for the Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) market considering competitive landscape, development trends, and key critical success factors (CSFs) prevailing in the Induced Pluripotent Stem Cells (iPSCs) industry.
Historical Forecast Period
2014 - 2016 – Historical Year for Induced Pluripotent Stem Cells (iPSCs) Market
2017 – Base Year for Induced Pluripotent Stem Cells (iPSCs) Market
2019-2026 – Forecast Period for Induced Pluripotent Stem Cells (iPSCs) Market
Key Developments in the Induced Pluripotent Stem Cells (iPSCs) Market
To describe Induced Pluripotent Stem Cells (iPSCs) Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
To analyze the manufacturers of Induced Pluripotent Stem Cells (iPSCs), with profile, main business, news, sales, price, revenue and market share in 2016 and 2018;
To display the competitive situation among the top manufacturers in Asia-Pacific, with sales, revenue and market share in 2016 and 2018;
To show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2014 to 2019;
To analyze the key countries by manufacturers, Type and Application, covering China, Japan, Korea, Taiwan，Southeast Asia，India, and Australia, with sales, revenue and market share by manufacturers, types and applications;
Induced Pluripotent Stem Cells (iPSCs) market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2026;
To analyze the manufacturing cost, key raw materials and manufacturing process etc.
To analyze the industrial chain, sourcing strategy and downstream end users (buyers);
To describe Induced Pluripotent Stem Cells (iPSCs) sales channel, distributors, traders, dealers etc.
To describe Induced Pluripotent Stem Cells (iPSCs) Research Findings and Conclusion, Appendix, methodology and data source
Market Segment by Manufacturers, this report covers
• Fujifilm Holding Corporation (CDI)
• ReproCELL
• Astellas Pharma Inc
• Ncardia
• Cell Inspire Biotechnology
• Sumitomo Dainippon Pharma
• Pluricell Biotech
• Fate Therapeutics, Inc
Market Segment by Countries, covering
• China Market Revenue and/or Volume
• Japan Market Revenue and/or Volume
• Korea Market Revenue and/or Volume
• Taiwan Market Revenue and/or Volume
• Southeast Asia Market Revenue and/or Volume
• India Market Revenue and/or Volume
• Australia Market Revenue and/or Volume
Market Segment by Type, covers
• Human iPSCs
• Mouse iPSCs
Market Segment by Applications, can be divided into
• Academic Research
• Drug Development and Discovery
• Toxicity Screening
• Regenerative Medicine


Companies:


Key Players:
Fujifilm Holding Corporation (CDI)
ReproCELL
Astellas Pharma Inc
Ncardia
Cell Inspire Biotechnology
Sumitomo Dainippon Pharma
Pluricell Biotech